Working partners in sickness and in health

Partenrship: Ingham Institute Chairman, Terry Goldacre, with SWSLHD chief executive Amanda Larkin
Partenrship: Ingham Institute Chairman, Terry Goldacre, with SWSLHD chief executive Amanda Larkin

A great partnership between the Ingham Institute and South Western Sydney Local Health District (SWSLHD) has been formed that will progress innovative and ground-breaking advances in medical science.  

The new partnership agreement will see medical researchers continue working hand-in-hand with hospitals in Liverpool, Campbelltown, Bankstown, Fairfield, Bowral and health services across the district.

“This is something we hope our community will be excited about, and proud of,’’  Ingham Institute Chairman, Terry Goldacre said.

“Together with Western Sydney University and UNSW Australia the Ingham Institute forms a unique collaboration in Australia, with far-reaching benefits, not only for those experiencing ill-health today, but those in the future because it will enable us to discover further advances in treatment.”

SWSLHD chief executive Amanda Larkin said, "Having a world-class research institute on the doorstep of the District’s hospitals meant staff were partnering in hundreds of projects and clinical trials.”

“This partnership agreement ensures the world class research being undertaken in south-western Sydney will continue well into the future. There are more than 200 clinical trials to find new ways for treating major health issues currently under way in this health district, and the Ingham Institute is involved in most of them," Ms Larkin said.

One such collaboration centres around one of the Ingham Institute's newest technical innovations, a microscope - christened Merlin - that allows scientists to view the inside of a cancer cell down to its DNA.

With this equipment and working with Liverpool Hospital's pathology unit, researchers will be able to get to the heart of why circulating tumour cells (CTCs) − the vehicles that cause mature cancer to spread − behave the way they do and find how best to kill them.

“The potential for vastly improving the quality of care and life expectancy of people struck with this disease thanks to collaborations like this one, give Amanda, myself and the hundreds of researchers and medical professionals across the Ingham Institute and SWSLHD much hope for what we can achieve together in the future,” Mr Goldacre said.